March 06, 2015
A California federal judge declined to invalidate two Genentech Inc. patents covering biotechnology used to make drugs for cancer and autoimmune diseases, ruling Thursday that Eli Lilly and Co.'s arguments that the method was double-patented were unpersuasive.
October 30, 2013
Genentech Inc. on Wednesday urged a California federal judge to trim a suit seeking to invalidate its patents for a blood cancer treatment, saying Eli Lilly and Co. had failed to show a Genentech attorney and others engaged in inequitable conduct in prosecuting the patents.